Adlai Nortye Group Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ANL Nasdaq 2830 www.adlainortye.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adlai Nortye Group Ltd.

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress - Aug 14th, 2026 5:00 am
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia - Aug 3rd, 2026 5:00 am
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 - Jul 16th, 2026 5:00 am
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists - Jul 13th, 2026 5:00 am
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT - May 1st, 2026 2:18 am
Adlai Nortye (ANL): 10 Tiny Stocks That Are On Fire Right Now - Apr 29th, 2026 11:00 am
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing - Apr 16th, 2026 5:00 am
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Apr 10th, 2026 7:40 am
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why - Mar 19th, 2026 10:00 am
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations - Feb 12th, 2026 2:00 am
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing - Feb 3rd, 2026 5:00 am
Wall Street Set to Open Lower Friday as Investors React to Trump's Choice of Warsh as Fed Chair - Jan 30th, 2026 7:14 am
Investors Calmed by Trump's Choice of Warsh as Fed Chair, Look Ahead to Inflation Data - Jan 30th, 2026 5:59 am
Individual investors are Adlai Nortye Ltd.'s (NASDAQ:ANL) biggest owners and were rewarded after market cap rose by US$65m last week - Jan 28th, 2026 4:22 am
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - Dec 29th, 2025 4:00 am
Adlai Nortye to Participate in Upcoming Investor Conferences - Nov 21st, 2025 6:00 am